Ken Fisher Bridge Bio Pharma, Inc. Transaction History

Fisher Asset Management, LLC

  • $243 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022
SELL
$7.34 - $17.16 $5.6 Million - $13.1 Million
-763,531 Closed
0 $0
Q4 2021

Feb 02, 2022
BUY
$11.38 - $53.41 $2.21 Million - $10.4 Million
194,266 Added 34.13%
763,531 $12.7 Million
Q3 2021

Oct 26, 2021
BUY
$46.87 - $64.24 $26.7 Million - $36.6 Million
569,265 New
569,265 $26.7 Million

Others Institutions Holding BBIO

# of Institutions
291
Shares Held
171M
Call Options Held
10.4M
Put Options Held
2.37M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.47B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email